Publications by authors named "E Colajori"

Claim this Profile
S
Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial.
R C Coombes, L S Kilburn, C F Snowdon, R Paridaens, R E Coleman, E Colajori

Lancet· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting the maximum-tolerated dose of PNU-159548 (4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin) in humans using CFU-GM clonogenic assays and prospective validation.
D Moneta, C Geroni, O Valota, P Grossi, M J A de Jonge, E Colajori

Eur J Cancer· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-intensive epirubicin-based chemotherapy is superior to an intensive intravenous cyclophosphamide, methotrexate, and fluorouracil regimen in metastatic breast cancer: a randomized multinational study.
S P Ackland, A Anton, G P Breitbach, E Colajori, J M Tursi

J Clin Oncol· February 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Doubling epirubicin dose intensity (100 mg/m2 versus 50 mg/m2) in the FEC regimen significantly increases response rates. An international randomised phase III study in metastatic breast cancer. The Epirubicin High Dose (HEPI 010) Study Group.
G Brufman, E Colajori, N Ghilezan, M Lassus, A Martoni

Ann Oncol· February 1997

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study with iododoxorubicin in measurable advanced colorectal adenocarcinoma. Effective rescue using weekly high-dose 5-fluorouracil (WFU). Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD), Work Group of SEOM (Spanish Medical Oncology Society).
A Villar-Grimalt, E Aranda, B Massutí, J Belón, A Antón, E Colajori

Tumori· April 1994

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis